Assenagon Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1M | Hold |
2,039,987
| – | – | 0.03% | 339 |
|
|
2025
Q1 | $25.1M | Sell |
2,039,987
-24,469
| -1% | -$301K | 0.04% | 280 |
|
|
2024
Q4 | $27.3M | Buy |
2,064,456
+1,598,428
| +343% | +$21.1M | 0.04% | 288 |
|
|
2024
Q3 | $8.97M | Buy |
466,028
+37,079
| +9% | +$714K | 0.02% | 539 |
|
|
2024
Q2 | $8.81M | Buy |
428,949
+151,021
| +54% | +$3.1M | 0.02% | 445 |
|
|
2024
Q1 | $6.61M | Sell |
277,928
-134,037
| -33% | -$3.19M | 0.02% | 506 |
|
|
2023
Q4 | $8.9M | Buy |
411,965
+21,427
| +5% | +$463K | 0.02% | 455 |
|
|
2023
Q3 | $5.67M | Buy |
390,538
+125,893
| +48% | +$1.83M | 0.02% | 524 |
|
|
2023
Q2 | $5.54M | Sell |
264,645
-74,947
| -22% | -$1.57M | 0.02% | 455 |
|
|
2023
Q1 | $7.17M | Buy |
339,592
+329,577
| +3,291% | +$6.96M | 0.03% | 450 |
|
|
2022
Q4 | $255K | Sell |
10,015
-10,106
| -50% | -$257K | ﹤0.01% | 1227 |
|
|
2022
Q3 | $484K | Sell |
20,121
-190,623
| -90% | -$4.59M | ﹤0.01% | 1059 |
|
|
2022
Q2 | $4.06M | Buy |
+210,744
| New | +$4.06M | 0.02% | 585 |
|
|
2022
Q1 | – | Sell |
-283,954
| Closed | -$6.22M | – | 1496 |
|
|
2021
Q4 | $6.22M | Buy |
+283,954
| New | +$6.22M | 0.02% | 427 |
|
|
2020
Q4 | – | Sell |
-169,792
| Closed | -$2.51M | – | 1196 |
|
|
2020
Q3 | $2.51M | Sell |
169,792
-8,400
| -5% | -$124K | 0.01% | 507 |
|
|
2020
Q2 | $2.64M | Buy |
+178,192
| New | +$2.64M | 0.02% | 489 |
|